NO930206D0 - Farmasoeytiske blandinger - Google Patents

Farmasoeytiske blandinger

Info

Publication number: NO930206D0
Authority: NO; Norway
Prior art keywords: pharmaceutical mixtures; psoriasis; malignant; esters; salts
Prior art date: 1992-01-22

Application number

NO930206A

Other languages

English (en)

Other versions

NO302274B1 (no

NO930206L (no

Inventor

Werner Bollag

Joseph Francis Grippo

Arthur Levin

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-22

Filing date

1993-01-21

Publication date

1993-01-21

1993-01-21 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1993-01-21 Publication of NO930206D0 publication Critical patent/NO930206D0/no

1993-07-23 Publication of NO930206L publication Critical patent/NO930206L/no

1998-02-16 Publication of NO302274B1 publication Critical patent/NO302274B1/no

Links

239000000203 mixture Substances 0.000 title 1
SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
229960001445 alitretinoin Drugs 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000009841 epithelial lesion Effects 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
230000003211 malignant effect Effects 0.000 abstract 1
230000008832 photodamage Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
210000002374 sebum Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Fats And Perfumes (AREA)

NO930206A 1992-01-22 1993-01-21 Anvendelse av 9-cis retinsyre NO302274B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US82374192A	1992-01-22	1992-01-22
US82392892A	1992-01-22	1992-01-22
US82378692A	1992-01-22	1992-01-22
US82464792A	1992-01-23	1992-01-23

Publications (3)

Publication Number	Publication Date
NO930206D0 true NO930206D0 (no)	1993-01-21
NO930206L NO930206L (no)	1993-07-23
NO302274B1 NO302274B1 (no)	1998-02-16

Family

ID=27505866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO930206A NO302274B1 (no)	1992-01-22	1993-01-21	Anvendelse av 9-cis retinsyre

Country Status (20)

Country	Link
EP (1)	EP0552624B1 (no)
JP (1)	JP3631259B2 (no)
CN (2)	CN1068200C (no)
AT (1)	ATE194077T1 (no)
AU (1)	AU667864B2 (no)
CA (1)	CA2087251C (no)
CY (1)	CY2251B1 (no)
CZ (1)	CZ282548B6 (no)
DE (1)	DE69328910T2 (no)
DK (1)	DK0552624T3 (no)
ES (1)	ES2148184T3 (no)
GR (1)	GR3034323T3 (no)
HU (2)	HU212734B (no)
IL (1)	IL104450A (no)
NO (1)	NO302274B1 (no)
NZ (1)	NZ245686A (no)
PH (1)	PH31621A (no)
PT (1)	PT552624E (no)
RU (1)	RU2119333C1 (no)
TW (1)	TW226329B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5968989A (en)	1991-12-18	1999-10-19	The Salk Institute For Biological Studies	Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en)	1991-12-18	2006-06-06	The Salk Institute For Biological Studies	Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
EP0617614B1 (en)	1991-12-18	1998-03-04	The Salk Institute For Biological Studies	Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5780676A (en) *	1992-04-22	1998-07-14	Ligand Pharmaceuticals Incorporated	Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5962731A (en) *	1992-04-22	1999-10-05	Ligand Pharmaceuticals Incorporated	Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7655699B1 (en)	1992-04-22	2010-02-02	Eisai Inc.	Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5549888A (en) *	1994-01-31	1996-08-27	Procter & Gamble	Aqueous topical anti-acne compositions of low pH
US5534261A (en) *	1995-01-17	1996-07-09	University Of Southern California	Retinoid-based compositions and method for preventing adhesion formation using the same
US7115728B1 (en)	1995-01-30	2006-10-03	Ligand Pharmaceutical Incorporated	Human peroxisome proliferator activated receptor γ
US5821254A (en) *	1995-02-17	1998-10-13	The United States Of America As Represented By The Department Of Health And Human Services	Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
US5807900A (en) *	1995-03-31	1998-09-15	Hoffmann-La Roche, Inc.	Method for identifying compounds having increased activity for the repair of skin photodamage
CA2218685A1 (en) *	1995-04-21	1996-10-24	Ligand Pharmaceuticals Incorporated	Inhibition of apoptosis in cells expressing fas-ligand following activation
DE19523079A1 (de) *	1995-06-26	1997-01-02	Basf Ag	Ester und Amide der 9(Z)-Retinsäure
WO1997010813A1 (en)	1995-09-18	1997-03-27	Ligand Pharmaceuticals Incorporated	Ppar gamma antagonists for treating obesity
DK0859608T3 (da) *	1995-09-18	2004-06-14	Ligand Pharm Inc	Behandling af NIDDM med RXR-agonister
TW442459B (en) *	1996-04-15	2001-06-23	Hoffmann La Roche	Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
FR2765480B1 (fr)	1997-07-07	1999-09-10	Oreal	Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
US7098025B1 (en)	1997-07-25	2006-08-29	Ligand Pharmaceuticals Incorporated	Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
WO1999048529A1 (en) *	1998-03-20	1999-09-30	Warner-Lambert Company	Retinoid-glitazone combinations
PL351878A1 (en)	1999-04-07	2003-06-30	Sankyo Co	Amino compound derivatives
AU3082901A (en) *	1999-11-23	2001-06-04	Gerhart Graupner	Modulation of signal transduction
RU2214830C2 (ru) *	2001-12-03	2003-10-27	Рязанский государственный медицинский университет им. акад. И.П.Павлова	Способ лечения и профилактики местных лучевых реакций на коже
JP5249484B2 (ja) *	2001-12-11	2013-07-31	第一三共株式会社	医薬組成物
RU2197235C1 (ru) *	2002-04-05	2003-01-27	Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа)	Раствор для лечения заболеваний кожи, способ его получения и способ лечения заболеваний кожи
EP1496879A4 (en) *	2002-04-05	2008-06-18	Univ Utah Res Found	Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
WO2004022042A1 (en) *	2002-09-06	2004-03-18	Oregon Health And Science University	Effect of vitamin a gel on paranasal sinus mucosal regeneration
EP1527774A1 (en) *	2003-11-03	2005-05-04	Basilea Pharmaceutica AG	New formulation for retinoid-containing soft gelatin capsules
JP4825957B2 (ja) *	2005-03-29	2011-11-30	国立大学法人鹿児島大学	抗腫瘍剤
MX2012003220A (es)	2009-09-15	2012-08-03	Quadra Logic Tech Inc	Formulaciones farmaceuticas que comprenden 9-cis-retinil esteres en un vehiculo de lipido.
US20130317096A1 (en) *	2010-04-16	2013-11-28	Davos Life Science Pte Ltd	Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
KR101851249B1 (ko)	2010-04-19	2018-06-20	노벨리언 테라퓨틱스 인코포레이티드	내인성 레티노이드 결핍과 연관된 시각 장애의 치료 또는 완화를 위한 치료용 조성물, 제형 및 키트
KR102133608B1 (ko)	2012-03-01	2020-07-13	레티나제닉스, 엘엘씨	내인성 레티노이드 결핍증과 관련된 시각 장애에서 시각 기능의 개선을 위한 치료 요법 및 방법
JP6182728B2 (ja) *	2012-11-02	2017-08-23	国立大学法人名古屋大学	幹細胞を標的とした薬効及び毒性の評価法
WO2022051831A1 (pt)	2020-09-11	2022-03-17	Chemyunion Ltda.	Composição, uso de composição, método cosmético e método para modular a produção de sebo
IL315396A (en) *	2022-03-08	2024-11-01	Mastery Biotech Co Ltd	Pharmaceutical composition including retinoic acid and carbohydrate and use thereof
WO2025077810A1 (zh) *	2023-10-12	2025-04-17	南京纽邦生物科技有限公司	预防或延缓皮肤衰老及维持或改善皮肤状况的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA713539B (en) *	1970-06-23	1972-02-23	Hoffmann La Roche	Pharmaceutical compositions
CA1326633C (en) *	1987-04-06	1994-02-01	Gerd Plewig	Treatment of aged skin with oral 13-cis-retinoic acid
US4994491A (en) *	1988-12-14	1991-02-19	Molecular Design International	Dermal uses of trans-retinoids for the treatment of cancer
LU86969A1 (fr) *	1987-08-12	1989-03-08	Oreal	Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute
EP0617614B1 (en) *	1991-12-18	1998-03-04	The Salk Institute For Biological Studies	Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

1992
- 1992-12-17 CZ CS923728A patent/CZ282548B6/cs not_active IP Right Cessation
- 1992-12-24 TW TW081110357A patent/TW226329B/zh active
1993
- 1993-01-11 PT PT93100257T patent/PT552624E/pt unknown
- 1993-01-11 DK DK93100257T patent/DK0552624T3/da active
- 1993-01-11 DE DE69328910T patent/DE69328910T2/de not_active Expired - Lifetime
- 1993-01-11 AT AT93100257T patent/ATE194077T1/de not_active IP Right Cessation
- 1993-01-11 ES ES93100257T patent/ES2148184T3/es not_active Expired - Lifetime
- 1993-01-11 EP EP93100257A patent/EP0552624B1/en not_active Expired - Lifetime
- 1993-01-13 CA CA002087251A patent/CA2087251C/en not_active Expired - Fee Related
- 1993-01-15 NZ NZ245686A patent/NZ245686A/en not_active IP Right Cessation
- 1993-01-18 HU HU9300116A patent/HU212734B/hu not_active IP Right Cessation
- 1993-01-18 AU AU31861/93A patent/AU667864B2/en not_active Expired
- 1993-01-19 PH PH45577A patent/PH31621A/en unknown
- 1993-01-20 RU RU93005355A patent/RU2119333C1/ru not_active IP Right Cessation
- 1993-01-20 IL IL104450A patent/IL104450A/xx not_active IP Right Cessation
- 1993-01-20 JP JP02342993A patent/JP3631259B2/ja not_active Expired - Fee Related
- 1993-01-21 NO NO930206A patent/NO302274B1/no not_active IP Right Cessation
- 1993-01-21 CN CN93100632A patent/CN1068200C/zh not_active Expired - Fee Related
1995
- 1995-06-19 HU HU95P/P00256P patent/HU211167A9/hu unknown
1999
- 1999-12-15 CN CNB99126469XA patent/CN1155376C/zh not_active Expired - Fee Related
2000
- 2000-09-04 GR GR20000402010T patent/GR3034323T3/el not_active IP Right Cessation
2001
- 2001-12-11 CY CY0100043A patent/CY2251B1/xx unknown

Also Published As

Publication number	Publication date
CA2087251C (en)	2003-06-24
DE69328910T2 (de)	2001-01-11
AU667864B2 (en)	1996-04-18
JPH06107542A (ja)	1994-04-19
PT552624E (pt)	2000-10-31
ES2148184T3 (es)	2000-10-16
CY2251B1 (en)	2003-07-04
EP0552624A1 (en)	1993-07-28
IL104450A (en)	1997-03-18
HUT63053A (en)	1993-07-28
CZ372892A3 (en)	1993-12-15
HU9300116D0 (en)	1993-04-28
PH31621A (en)	1999-01-12
RU2119333C1 (ru)	1998-09-27
DE69328910D1 (de)	2000-08-03
CN1155376C (zh)	2004-06-30
CN1074826A (zh)	1993-08-04
NZ245686A (en)	1995-05-26
CN1068200C (zh)	2001-07-11
NO302274B1 (no)	1998-02-16
HU212734B (en)	1996-10-28
CN1256916A (zh)	2000-06-21
JP3631259B2 (ja)	2005-03-23
EP0552624B1 (en)	2000-06-28
TW226329B (no)	1994-07-11
CA2087251A1 (en)	1993-07-23
HU211167A9 (en)	1995-11-28
DK0552624T3 (da)	2000-09-25
GR3034323T3 (en)	2000-12-29
ATE194077T1 (de)	2000-07-15
AU3186193A (en)	1993-07-29
NO930206L (no)	1993-07-23
IL104450A0 (en)	1993-05-13
CZ282548B6 (cs)	1997-08-13

Legal Events

Date	Code	Title	Description
2011-09-05	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO930206L (no)	1993-07-23	Farmasoeytiske blandinger
RU93005355A (ru)	1995-09-27	Фармакологические композиции
DE3850109D1 (de)	1994-07-14	13-trans-retinsäureester.
IT1223290B (it)	1990-09-19	Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
ATE181231T1 (de)	1999-07-15	Verfahren zur hautpflege und mittel
GR3022519T3 (en)	1997-05-31	Use of ketoconazole and a retinoid for the treatment of acne vulgaris
DE69315927D1 (de)	1998-02-05	Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
KR930016100A (ko)	1993-08-26	약제학적 조성물
DE3485337D1 (de)	1992-01-23	Topische zubereitungen mit gehalt an teer und fettsaeuren.
NO308579B1 (no)	2000-10-02	Anvendelse av aromatiske karboksylsyrederivater til fremstilling av farmasøytiske preparater for terapi og profylakse av lys- og aldersbetingede hudskader, og for Õ fremme sÕrhelbredelse, samt nye forbindelser
DE69029625D1 (de)	1997-02-20	Verwendung von Retinoiden zur Umkehr glucocorticoid-induzierter Hautatrophie
IT1189097B (it)	1988-01-28	Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi
ATE113209T1 (de)	1994-11-15	Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
TR199700694T1 (xx)	1998-02-21	D vitamini t�revlerinin dermotolojik kullan�m�.
ES2064958T3 (es)	1995-02-01	Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.
DE69018570D1 (de)	1995-05-18	Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
EP0968707A3 (de)	2003-08-13	Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
EP0357646A4 (en)	1991-05-08	Treatment of aged skin with oral 13-cis-retinoic acid
IT1242478B (it)	1994-03-17	Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.
ATE97812T1 (de)	1993-12-15	Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
DE59002393D1 (de)	1993-09-23	Verwendung von 2',4',6'-trimethoxy-4-(1-pyrrolidinyl)butyrophenon zur lokalen behandlung von trophischen erkrankungen.
DE3880778D1 (de)	1993-06-09	Therapeutisches mittel, das einen extrakt von impatiens capensis enthaelt.
IT1236394B (it)	1993-02-26	Agente anti psoriasi a base di salicilato di papaverina
ITBL930018A0 (it)	1993-08-24	Metodo per la produzione di unguento per malattie della pelle ed un- guento cosi' ottenuto